GT
36
-3
PLD
30
-16
GD
46
-3
SHW
45
-11
CCI
30
-3
MAC
55
-3
ADBE
56
-2
ZION
65
-2
ADSK
54
-3
SWKS
53
-4
WFC
71
-3
HD
41
-3
XRAY
22
-3
XRX
41
-5
BEN
40
4
CMS
65
-2
COST
54
-2
CME
45
3
JBHT
40
-3
ROP
50
-4
GT
36
-3
PLD
30
-16
GD
46
-3
SHW
45
-11
CCI
30
-3
MAC
55
-3
ADBE
56
-2
ZION
65
-2
ADSK
54
-3
SWKS
53
-4
WFC
71
-3
HD
41
-3
XRAY
22
-3
XRX
41
-5
BEN
40
4
CMS
65
-2
COST
54
-2
CME
45
3
JBHT
40
-3
ROP
50
-4
Financhill
Back

Arcus Biosciences Vs. Entrada Therapeutics Industry Stock Comparison

Sell
21

RCUS
Arcus Biosciences

Last Price:
$8.93
Seasonality Move:
0.88%
Sell
42

TRDA
Entrada Therapeutics

Last Price:
$7.75
Seasonality Move:
51.54%
Sell
21
Arcus Biosciences (RCUS) is a Sell

Is Arcus Biosciences a Buy, Sell or Hold?

  • The current Arcus Biosciences [RCUS] share price is $9.08. The Score for RCUS is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • RCUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Entrada Therapeutics (TRDA) is a Sell

Is Entrada Therapeutics a Buy, Sell or Hold?

  • The current Entrada Therapeutics [TRDA] share price is $7.90. The Score for TRDA is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • TRDA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RCUS Stock Price Chart

What is Arcus Biosciences's stock price today?

  • The Arcus Biosciences share price today is $9.08
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCUS is experiencing selling pressure, which indicates risk of future bearish movement.

TRDA Stock Price Chart

What is Entrada Therapeutics's stock price today?

  • The Entrada Therapeutics share price today is $7.90
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TRDA is experiencing selling pressure, which indicates risk of future bearish movement.

RCUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.3 Buy
Relative Strength Index (14 RSI): 49.21 Sell
Chaikin Money Flow: -1769476 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.49 - 9.59) Buy
Bollinger Bands (100): (7.85 - 11.83) Sell

TRDA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 45.44 Sell
Chaikin Money Flow: -79218 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.75 - 8.41) Sell
Bollinger Bands (100): (8.01 - 12.15) Sell

RCUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.68 Sell
20-day SMA: 9.18 Sell
50-day SMA: 8.51 Buy
200-day SMA: 13.06 Sell
8-day EMA: 9.56 Sell
20-day EMA: 9.27 Sell
50-day EMA: 9.16 Sell
200-day EMA: 11.97 Sell

TRDA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.13 Sell
20-day SMA: 7.96 Sell
50-day SMA: 8.26 Sell
200-day SMA: 13.61 Sell
8-day EMA: 8.07 Sell
20-day EMA: 8.1 Sell
50-day EMA: 8.7 Sell
200-day EMA: 12.08 Sell

Arcus Biosciences Earnings Growth & RCUS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.11 per share, a decrease this year of $1.52 per share, and a decrease next year of $0.11 per share.

Entrada Therapeutics Earnings Growth & TRDA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.27 per share, a decrease this year of $4.26 per share, and a decrease next year of $0.98 per share.

Arcus Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Entrada Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):